GW01-200
/ Groovy Medicine
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 15, 2026
GW01-200-01: A Phase I Trial of GW01-200 Tablets in Subjects With Advanced Tumors
(clinicaltrials.gov)
- P1 | N=100 | Recruiting | Sponsor: Groovy Medicine (Hangzhou) Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • First-in-human • Hematological Malignancies • Oncology
1 to 1
Of
1
Go to page
1